HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Nakajima Selected Research

Proton Pump Inhibitors

9/2020Percent reduction of the ulcer size at 4 weeks is a predictor of the complete healing of endoscopic submucosal dissection-induced gastric ulcers.
7/2017Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial.
1/2017Proton pump inhibitor therapy did not increase the prevalence of small-bowel injury: A propensity-matched analysis.
7/2014The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver disease.
11/2009Clinical study of upper gastrointestinal bleeding associated with low-dose aspirin in Japanese patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Nakajima Research Topics

Disease

116Non-alcoholic Fatty Liver Disease
03/2024 - 10/2006
78Neoplasms (Cancer)
05/2024 - 02/2003
65Fibrosis (Cirrhosis)
03/2024 - 06/2005
35Inflammation (Inflammations)
11/2023 - 08/2002
33Carcinogenesis
11/2023 - 04/2002
32Hemorrhage
01/2024 - 01/2004
31Insulin Resistance
11/2023 - 07/2002
26Aberrant Crypt Foci
10/2022 - 04/2002
26Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 02/2007
25Liver Cirrhosis (Hepatic Cirrhosis)
03/2024 - 10/2008
25Obesity
11/2023 - 06/2003
23Constipation
02/2024 - 01/2017
17Liver Diseases (Liver Disease)
11/2023 - 10/2007
16Hepatocellular Carcinoma (Hepatoma)
01/2024 - 12/2004
15Colonic Neoplasms (Colon Cancer)
05/2024 - 04/2002
15Alcoholic Fatty Liver
01/2022 - 04/2005
14Body Weight (Weight, Body)
01/2022 - 09/2002
14Adenoma (Adenomas)
10/2020 - 06/2003
13Type 2 Diabetes Mellitus (MODY)
11/2021 - 06/2006
12Pancreatic Neoplasms (Pancreatic Cancer)
07/2021 - 02/2006
12Colitis
05/2014 - 07/2002
11Polyps
10/2022 - 01/2007
11Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017 - 07/2002
10Diabetes Mellitus
01/2022 - 11/2008
10Ulcer
09/2020 - 01/2004
9Infections
01/2023 - 03/2005
9Adenocarcinoma
05/2020 - 10/2007
8Pancreatitis
12/2023 - 12/2008
7Neoplasm Metastasis (Metastasis)
01/2023 - 06/2005
6Fatty Liver
11/2023 - 07/2014
6Autoimmune Pancreatitis
01/2023 - 01/2010
6Stomach Neoplasms (Stomach Cancer)
01/2013 - 06/2005
6Peptic Ulcer (Peptic Ulcers)
01/2012 - 01/2009
6Carcinoma (Carcinomatosis)
10/2011 - 03/2005
6Ulcerative Colitis
01/2011 - 08/2002
5Opioid-Induced Constipation
03/2024 - 06/2020
5Abdominal Pain (Pain, Abdominal)
01/2024 - 01/2018
5Hypertension (High Blood Pressure)
12/2022 - 12/2007
5Dysbiosis
07/2021 - 01/2017
5Chronic Renal Insufficiency
02/2021 - 01/2013
5Gastroesophageal Reflux (GERD)
11/2020 - 09/2008

Drug/Important Bio-Agent (IBA)

39Biomarkers (Surrogate Marker)IBA
12/2023 - 05/2007
24PPAR gammaIBA
01/2010 - 07/2002
21Proteins (Proteins, Gene)FDA Link
02/2024 - 08/2002
18Alanine Transaminase (SGPT)IBA
11/2023 - 05/2007
16LipidsIBA
12/2023 - 01/2007
16Insulin (Novolin)FDA Link
02/2023 - 06/2003
16LigandsIBA
11/2011 - 07/2002
15Glucose (Dextrose)FDA LinkGeneric
03/2024 - 06/2003
13Triglycerides (Triacylglycerol)IBA
11/2023 - 01/2007
13Pioglitazone (Actos)FDA Link
01/2022 - 07/2002
13Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2020 - 01/2009
12elobixibatIBA
01/2024 - 01/2018
12Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2023 - 05/2007
11Protons (Proton)IBA
12/2023 - 01/2020
11Collagen Type IV (Type IV Collagen)IBA
06/2023 - 05/2007
11Capsules (Microcapsules)IBA
01/2022 - 01/2007
10Messenger RNA (mRNA)IBA
10/2021 - 06/2005
10Metformin (Glucophage)FDA LinkGeneric
10/2020 - 11/2008
9AdiponectinIBA
02/2023 - 01/2007
8Opioid Analgesics (Opioids)IBA
03/2024 - 03/2018
8CholesterolIBA
11/2023 - 01/2008
8Bile Acids and Salts (Bile Acids)IBA
11/2023 - 01/2018
8AcidsIBA
10/2023 - 01/2004
8EnzymesIBA
10/2023 - 06/2003
8HDL CholesterolIBA
08/2023 - 01/2007
8Indicators and Reagents (Reagents)IBA
01/2022 - 10/2005
8LeptinIBA
09/2014 - 05/2009
8AzoxymethaneIBA
12/2013 - 04/2002
8Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
04/2008 - 07/2002
7CytokinesIBA
02/2023 - 07/2002
7EndotoxinsIBA
10/2022 - 07/2012
7Ferritins (Ferritin)IBA
10/2022 - 10/2005
7Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2015 - 03/2006
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2012 - 09/2002
7Dextrans (Dextran)FDA Link
01/2012 - 09/2002
7sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2012 - 09/2002
6Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2024 - 01/2012
6LDL CholesterolIBA
11/2023 - 01/2007
6SteroidsIBA
03/2023 - 01/2010
6GemcitabineFDA Link
04/2021 - 02/2006
6Therapeutic UsesIBA
03/2021 - 07/2012
6Hemoglobins (Hemoglobin)IBA
02/2021 - 12/2002
6BiguanidesIBA
10/2020 - 11/2008
6Dehydroepiandrosterone (DHEA)IBA
02/2007 - 04/2002
5Magnesium Oxide (Magnesia)FDA Link
03/2024 - 06/2020
5linaclotideIBA
01/2024 - 12/2018
5LubiprostoneFDA Link
01/2024 - 01/2017
5RNA (Ribonucleic Acid)IBA
11/2023 - 06/2006
5Small Interfering RNA (siRNA)IBA
11/2023 - 06/2005
5bile acid binding proteinsIBA
07/2022 - 01/2018
5Methylene Blue (Methylthioninium Chloride)FDA Link
10/2020 - 01/2012
5Proton Pump InhibitorsIBA
09/2020 - 11/2009

Therapy/Procedure

65Therapeutics
03/2024 - 08/2002
24Drug Therapy (Chemotherapy)
05/2024 - 02/2006
12Chemoprevention
10/2022 - 04/2002
11Liver Transplantation
01/2024 - 03/2011
10Stents
09/2023 - 01/2011
5Palliative Care (Palliative Therapy)
03/2024 - 02/2015
5Oral Administration
08/2023 - 12/2002